During the past decade, Reuma Instituut conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Reuma Instituut" #1 sponsor was "Pfizer" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored, "P. Verschueren" with 1 trials sponsored and "University Ghent" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reuma Instituut" #1 collaborator was "Belgium Health Care Knowledge Centre" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "the Flanders Institute for Biotechnology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Reuma Instituut" are "Rheumatoid Arthritis" (3 trials), "Arthritis, Psoriatic" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Axial Spondyloarthritis" (1 trials) and "Spondylitis, Ankylosing" (1 trials). Many other conditions were trialed in "Reuma Instituut" in a lesser frequency.

Most popular intervention types in "Reuma Instituut" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Background NSAID" (1 trials), "Etanercept 50 MG/ML" (1 trials), "Filgotinib" (1 trials), "Golimumab" (1 trials) and "ILV-094" (1 trials). Other intervention names were less common.

The vast majority of trials in "Reuma Instituut" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Reuma Instituut". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Reuma Instituut, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Reuma Instituut, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".